{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:59:34Z","timestamp":1794009574131,"version":"4.8.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,19]],"date-time":"2011-10-19T00:00:00Z","timestamp":1318982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2334-11-279","type":"journal-article","created":{"date-parts":[[2011,10,19]],"date-time":"2011-10-19T14:24:38Z","timestamp":1319034278000},"source":"Crossref","is-referenced-by-count":215,"title":["Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia"],"prefix":"10.1186","volume":"11","author":[{"given":"Marin L","family":"Schweizer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon P","family":"Furuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Kristie","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle D","family":"Shardell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessina C","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri A","family":"Thom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli N","family":"Perencevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,19]]},"reference":[{"key":"1614_CR1","volume-title":"Initial national priorities for comparative effectiveness research","author":"Institute of Medicine","year":"2009","unstructured":"Institute of Medicine: Initial national priorities for comparative effectiveness research. 2009, Washington DC: National Academies Pr"},{"issue":"8","key":"1614_CR2","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3201\/eid1308.061575","volume":"13","author":"JK Johnson","year":"2007","unstructured":"Johnson JK, Khoie T, Shurland S, Kreisel K, Stine OC, Roghmann MC: Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone. Emerg Infect Dis. 2007, 13 (8): 1195-200.","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"1614_CR3","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1172\/JCI38226","volume":"119","author":"FR DeLeo","year":"2009","unstructured":"DeLeo FR, Chambers HF: Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest. 2009, 119 (9): 2464-74. 10.1172\/JCI38226.","journal-title":"J Clin Invest"},{"issue":"3","key":"1614_CR4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ki.1996.393","volume":"50","author":"RH Barth","year":"1996","unstructured":"Barth RH, DeVincenzo N: Use of vancomycin in high-flux hemodialysis: Experience with 130 courses of therapy. Kidney Int. 1996, 50 (3): 929-36. 10.1038\/ki.1996.393.","journal-title":"Kidney Int"},{"issue":"26","key":"1614_CR5","first-page":"565","volume":"51","author":"Centers for Disease Control and Prevention (CDC)","year":"2002","unstructured":"Centers for Disease Control and Prevention (CDC): Staphylococcus aureus resistant to vancomycin--United States, 2002. MMWR Morb Mortal Wkly Rep. 2002, 51 (26): 565-7.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"1614_CR6","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1128\/AAC.01602-07","volume":"52","author":"TP Lodise","year":"2008","unstructured":"Lodise TP, Lomaestro B, Graves J, Drusano GL: Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother. 2008, 52 (4): 1330-6. 10.1128\/AAC.01602-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1614_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","volume":"82","author":"FY Chang","year":"2003","unstructured":"Chang FY, Peacock JE, Musher DM, Triplett P, MacDonald BB, Mylotte JM, et al: Staphylococcus aureus bacteremia: Recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 2003, 82 (5): 333-9. 10.1097\/01.md.0000091184.93122.09.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1614_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1086\/510386","volume":"44","author":"ME Stryjewski","year":"2007","unstructured":"Stryjewski ME, Szczech LA, Benjamin DK, Inrig JK, Kanafani ZA, Engemann JJ, et al: Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis. 2007, 44 (2): 190-6. 10.1086\/510386.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1614_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1128\/AAC.00700-07","volume":"52","author":"SH Kim","year":"2008","unstructured":"Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, et al: Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2008, 52 (1): 192-7. 10.1128\/AAC.00700-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1614_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1086\/345476","volume":"36","author":"SE Cosgrove","year":"2003","unstructured":"Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y: Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis. 2003, 36 (1): 53-9. 10.1086\/345476.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1614_CR11","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1128\/JCM.44.4.1342-1346.2006","volume":"44","author":"AR Marra","year":"2006","unstructured":"Marra AR, Edmond MB, Forbes BA, Wenzel RP, Bearman GM: Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection. J Clin Microbiol. 2006, 44 (4): 1342-6. 10.1128\/JCM.44.4.1342-1346.2006.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1614_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1128\/AAC.00901-06","volume":"51","author":"RB Osih","year":"2007","unstructured":"Osih RB, McGregor JC, Rich SE, Moore AC, Furuno JP, Perencevich EN, et al: Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother. 2007, 51 (3): 839-44. 10.1128\/AAC.00901-06.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1614_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1086\/518348","volume":"28","author":"JP Furuno","year":"2007","unstructured":"Furuno JP, Harris AD, Wright MO, Hartley DM, McGregor JC, Gaff HD, et al: Value of performing active surveillance cultures on intensive care unit discharge for detection of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007, 28 (6): 666-70. 10.1086\/518348.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"1614_CR14","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1378\/chest.100.6.1619","volume":"100","author":"WA Knaus","year":"1991","unstructured":"Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al: The APACHE III prognostic system, risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991, 100 (6): 1619-36. 10.1378\/chest.100.6.1619.","journal-title":"Chest"},{"issue":"3","key":"1614_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2307\/30142375","volume":"17","author":"JM Mylotte","year":"1996","unstructured":"Mylotte JM, Aeschlimann JR, Rotella DL: Staphylococcus aureus bacteremia: Factors predicting hospital mortality. Infect Control Hosp Epidemiol. 1996, 17 (3): 165-8. 10.1086\/647264.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"1614_CR16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/infdis\/173.4.914","volume":"173","author":"EP Yzerman","year":"1996","unstructured":"Yzerman EP, Boelens HA, Tjhie JH, Kluytmans JA, Mouton JW, Verbrugh HA: Delta APACHE II for predicting course and outcome of nosocomial Staphylococcus aureus bacteremia and its relation to host defense. J Infect Dis. 1996, 173 (4): 914-9. 10.1093\/infdis\/173.4.914.","journal-title":"J Infect Dis"},{"issue":"1","key":"1614_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3201\/eid1301.060716","volume":"13","author":"RH Sunenshine","year":"2007","unstructured":"Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, et al: Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis. 2007, 13 (1): 97-103. 10.3201\/eid1301.060716.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"1614_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992, 45 (6): 613-9. 10.1016\/0895-4356(92)90133-8.","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"1614_CR19","doi-asserted-by":"publisher","first-page":"e11432","DOI":"10.1371\/journal.pone.0011432","volume":"5","author":"ML Schweizer","year":"2010","unstructured":"Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, et al: Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: A retrospective cohort study. PLoS One. 2010, 5 (7): e11432-10.1371\/journal.pone.0011432.","journal-title":"PLoS One"},{"key":"1614_CR20","first-page":"M100","volume-title":"CLSI document","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibiliy testing. CLSI document. 2008, Nineteenth Informational Supplement ed., M100-S19."},{"issue":"4","key":"1614_CR21","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1128\/AAC.45.4.1292-1294.2001","volume":"45","author":"N Aritaka","year":"2001","unstructured":"Aritaka N, Hanaki H, Cui L, Hiramatsu K: Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Antimicrob Agents Chemother. 2001, 45 (4): 1292-4. 10.1128\/AAC.45.4.1292-1294.2001.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1614_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10156-007-0569-9","volume":"14","author":"T Oshiro","year":"2008","unstructured":"Oshiro T, Nagasawa Z, Hanaki H, Ikeda-Dantsuji Y, Nagayama A: The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin. J Infect Chemother. 2008, 14 (1): 15-22. 10.1007\/s10156-007-0569-9.","journal-title":"J Infect Chemother"},{"issue":"2","key":"1614_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1128\/AAC.00348-09","volume":"54","author":"C Joukhadar","year":"2010","unstructured":"Joukhadar C, Pillai S, Wennersten C, Moellering RC, Eliopoulos GM: Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus. Antimicrob Agents Chemother. 2010, 54 (2): 773-7. 10.1128\/AAC.00348-09.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"1614_CR24","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1128\/AAC.44.11.3206-3209.2000","volume":"44","author":"VK Dhawan","year":"2000","unstructured":"Dhawan VK, Bayer AS, Yeaman MR: Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother. 2000, 44 (11): 3206-9. 10.1128\/AAC.44.11.3206-3209.2000.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1614_CR25","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al: Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011, 52 (3): e18-55. 10.1093\/cid\/ciq146.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1614_CR26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1128\/AAC.34.6.1227","volume":"34","author":"PM Small","year":"1990","unstructured":"Small PM, Chambers HF: Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother. 1990, 34 (6): 1227-31.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"1614_CR27","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1128\/AAC.00101-07","volume":"51","author":"TP Lodise","year":"2007","unstructured":"Lodise TP, McKinnon PS, Levine DP, Rybak MJ: Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 2007, 51 (10): 3731-3. 10.1128\/AAC.00101-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1614_CR28","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/j.1875-9114.1997.tb03788.x","volume":"17","author":"CA Gentry","year":"1997","unstructured":"Gentry CA, Rodvold KA, Novak RM, Hershow RC, Naderer OJ: Retrospective evaluation of therapies for Staphylococcus aureus endocarditis. Pharmacotherapy. 1997, 17 (5): 990-7.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"1614_CR29","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1086\/313440","volume":"29","author":"C Gonzalez","year":"1999","unstructured":"Gonzalez C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo JJ: Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis. 1999, 29 (5): 1171-7. 10.1086\/313440.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1614_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/320869","volume":"33","author":"J Fortun","year":"2001","unstructured":"Fortun J, Navas E, Martinez-Beltran J, Perez-Molina J, Martin-Davila P, Guerrero A, et al: Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: Cloxacillin versus glycopeptides in combination with gentamicin. Clin Infect Dis. 2001, 33 (1): 120-5. 10.1086\/320869.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-11-279\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-279.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-279.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T18:34:40Z","timestamp":1713033280000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-11-279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,19]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1614"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-11-279","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717950650.793455950","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,19]]},"article-number":"279"}}